| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 10/11/2006 | CN1845902A Pesticidal 5-substituted-oxyalkylamino-1-arylpyrazole derivatives |
| 10/11/2006 | CN1845900A Quinoline derivatives as neutrophil elastase inhibitors and their use |
| 10/11/2006 | CN1845740A Piperazine derivatives for the treatment of HIV infections |
| 10/11/2006 | CN1845737A Method of stabilizing lipid-rich plaque and method of preventing rupture thereof |
| 10/11/2006 | CN1845734A Benzimidazole derivatives and their use as protein kinases inhibitors |
| 10/11/2006 | CN1845673A Pyridinylanilides |
| 10/11/2006 | CN1844119A Near infrared fluorescent probe for detecting zinc ion in cell and its synthesis method and use |
| 10/11/2006 | CN1844118A Piperidine-2,6-dione derivatives capable of inhibiting cell from releasing tumor necrosis factor |
| 10/11/2006 | CN1844107A Triazolinones compounds and their production method and use |
| 10/11/2006 | CN1844103A Pyrazol oxime ether derivatives and preparation process and use thereof |
| 10/11/2006 | CN1279038C Arthropodicidal anthranilamides |
| 10/11/2006 | CN1279027C Fungicidal 5-phenyl substituted 2-(cyanoamino) pyrimidines |
| 10/11/2006 | CN1279026C Prostaglandin endoperoxide H synthase biosynthesis inhibitors |
| 10/10/2006 | US7119214 dibenzofuranyl, dibenzothiophenyl or fluorenyl thioacetamides used for prophylaxis of sleep disorders |
| 10/10/2006 | US7119209 Process for preparing indolinone derivatives |
| 10/10/2006 | US7119207 NK-1 receptor antagonists, (e.g., substance P receptor antagonists) |
| 10/10/2006 | US7119204 phenanthroline compounds that exhibit electroluminescence, photoluminescence and/or photosensitivity, used in electrical apparatus such as organic light emitting diodes |
| 10/10/2006 | US7119203 Piperidinyl- and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors |
| 10/10/2006 | US7119201 Triaryl-oxy-aryloxy-pyrimidine-2,4,6-trione metalloproteinase inhibitors |
| 10/10/2006 | US7119196 Anxiolytic agents with reduced sedative and ataxic effects |
| 10/10/2006 | US7119115 For therapy of treating tumors or cancerous cells |
| 10/10/2006 | US7119114 Pyrazoloanthrone and derivatives thereof as JNK inhibitors and compositions and methods related thereto |
| 10/10/2006 | US7119108 Pyrazole derivatives as cannabinoid receptor antagonists |
| 10/10/2006 | US7119107 Pyridone derivatives |
| 10/10/2006 | US7119106 Pharmaceutical compositions of 1-oxo-2-(2,6-dioxopiperidin-3-yl)-4-aminoisoindoline |
| 10/10/2006 | US7119098 Antitumor agents; osteoporosis; antiarthritic agents; oral diseases |
| 10/10/2006 | US7119092 Chemical compounds |
| 10/10/2006 | US7119088 A bi-heterocycle-4H-2,3,5,10b-tetraaza-benzo[e]azulene derivatives; for therapy of dysmenorrhoea, anxiety disorder, asthma, atherosclerosis, cardiac failure, cardiovascular disease, cataract, central nervous system disease, motion sickness, Raynaud's disease, rheumatoid arthritis; chemical synthesis |
| 10/10/2006 | US7119086 Affinity and selectivity for arginine-vasopressin and/or ocytocin receptors; synthesis |
| 10/10/2006 | US7119084 4-amino-6-cycloalkyloxy-7-substituted quinazolines; inhibition of signal transduction mediated by tyrosine kinases; antitumor agents, respiratory system and gastrointestinal disorders |
| 10/10/2006 | US7119083 novel 2-(azetidin-2-on-1-yl)alkanedioic acid esters and amides useful for treating disease states that are associated with and responsive to antagonism of a vasopressin V1a receptor in a mammal |
| 10/10/2006 | US7119080 Boronic ester and acid compounds, synthesis and uses |
| 10/10/2006 | US7118811 Materials for light emitting devices consisting of novel compounds and light emitting devices using the same |
| 10/10/2006 | CA2352554C Substituted benzimidazoles and their use as parp inhibitors |
| 10/10/2006 | CA2336000C N-substituted piperazines and 1,4-disubstituted piperidines |
| 10/10/2006 | CA2274594C Aminopyrazole derivatives |
| 10/10/2006 | CA2255951C Substituted 3,5-diphenyl-1,2,4-triazoles and their use as pharmaceutical metal chelators |
| 10/10/2006 | CA2225366C Substituted purine derivatives, processes for their preparation, their use, and compositions comprising them |
| 10/10/2006 | CA2158862C Taxanes having alkoxy, alkenoxy or aryloxy substituted side-chain and pharmaceutical compositions containing same |
| 10/05/2006 | WO2006105304A2 Phenyl and pyridyl lta4h modulators |
| 10/05/2006 | WO2006105222A2 Carboxamide inhibitors of tgfb |
| 10/05/2006 | WO2006105023A1 Pyridine derivatives useful as inhibitors of pkc-theta |
| 10/05/2006 | WO2006104971A1 Atp competitive kinase inhibitors |
| 10/05/2006 | WO2006104713A1 Pyrimidindione derivatives as prokineticin 2 receptor antagonists |
| 10/05/2006 | WO2006104686A1 Piperazinyl substituted cyclohexane 1,4-diamines |
| 10/05/2006 | WO2006104280A1 Prophylactic/therapeutic agent for diabetes |
| 10/05/2006 | WO2006104161A1 THIENOPYRIDINE DERIVATIVE, OR QUINOLINE DERIVATIVE, OR QUINAZOLINE DERIVATIVE, HAVING c-Met AUTOPHOSPHORYLATION INHIBITING POTENCY |
| 10/05/2006 | WO2006104141A1 3-propenylcephem derivative |
| 10/05/2006 | WO2006104008A1 Urea derivative, medicinal composition containing the same, and medicinal use of these |
| 10/05/2006 | WO2006103688A1 A novel crystalline form of rupatadine free base |
| 10/05/2006 | WO2006103511A1 Cyclopentapyridine and tetrahydroquinoline derivatives |
| 10/05/2006 | WO2006103003A2 Substituted pyrazolyl oxyphenyl derivatives used as herbicides |
| 10/05/2006 | WO2006087630A3 OXYPYRAZOLE HMG Co-A REDUCTASE INHIBITORS |
| 10/05/2006 | WO2006078621A3 2-phenoxy-n- (1, 3 , 4-thiadizol-2-yl) pyridin-3-amine derivatives and related compounds as p2y1 receptor inhibitors for the treatment of thromboembolic disorders |
| 10/05/2006 | WO2006077387A3 Novel benzamide derivatives |
| 10/05/2006 | WO2006072458A3 Substituted oxindole derivatives, medicaments containing said derivatives and use thereof |
| 10/05/2006 | WO2006071609A3 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 10/05/2006 | WO2006064249A3 Process for the preparation of pantoprazole sodium |
| 10/05/2006 | WO2006059245A3 Compounds for the treatment of cns and amyloid associated diseases |
| 10/05/2006 | WO2006058012A3 Gonadotropin releasing hormone receptor antagonists |
| 10/05/2006 | WO2006048248A3 Novel anthranilamide pyridinureas as vegf receptor kinase imhibitors |
| 10/05/2006 | WO2006047196A3 Cgrp receptor antagonists |
| 10/05/2006 | WO2006026703A3 Chemical compounds |
| 10/05/2006 | WO2006011050A3 Pyridine derivatives |
| 10/05/2006 | WO2006010078A3 Polymorphic form of naratriptan hydrochloride |
| 10/05/2006 | WO2006004684A3 3-aminocyclopentanecarboxamides as modulators of chemokine receptors |
| 10/05/2006 | WO2005115392A8 3-(4-heteroarylcyclohexylamino) cyclopentanecarboxamides as modulators of chemokine receptors |
| 10/05/2006 | WO2004060308A3 Thiosemicarbazones as anti-virals and immunopotentiators |
| 10/05/2006 | US20060223890 N-arylsulfonyl-3-substituted indoles having serotonin receptor affinity, process for their preparation and pharmaceutical composition containing them |
| 10/05/2006 | US20060223886 Derivatives of N-[heteroaryl(piperidine-2-yl) methyl]benzamide, preparation method thereof and application of same in therapeutics |
| 10/05/2006 | US20060223885 Derivatives of N-phenyl (piperidine-2-yl) methyl benzamide, preparation method thereof and applications of same in therapeutics |
| 10/05/2006 | US20060223860 e.g. 3-(4-{[6-({(2R)-2-hydroxy-2-[4-hydroxy-3-(hydroxymethyl)-phenyl]ethyl}amino)-hexyl]oxy}butyl)benzenesulfonamide; beta 2 adrenergic receptor agonist and muscarinic receptor antagonist activity; bronchodilator agent; pulmonary disorders: chronic obstructive pulmonary dusease; asthma |
| 10/05/2006 | US20060223859 Chronic obstructive pulmonary dusease; asthma |
| 10/05/2006 | US20060223858 Chronic obstructive pulmonary dusease; asthma |
| 10/05/2006 | US20060223854 For therapy of thromboembolic and/or inflammatory disorders |
| 10/05/2006 | US20060223853 e.g. 1-[2-hydroxy-3-(quinolin-5-yloxy)-propyl]-piperidine-4-carboxylic acid [4-phenyl-1-(3-phenyl-propyl)-butyl]-amide; multidrug resistance protein or P-glycoprotein modulator; with other therapeutic agent: anticarcinogenic, antibacterial, antiviral, antifungal agents |
| 10/05/2006 | US20060223851 Triamide-substituted heterobicyclic compounds |
| 10/05/2006 | US20060223850 8-(3-Biaryl)phenylquinoline phosphodiesterase-4 inhibitors |
| 10/05/2006 | US20060223837 Biaryl derived amide modulators of vanilloid VR1 receptor |
| 10/05/2006 | US20060223836 New phenylalanine derivatives |
| 10/05/2006 | US20060223826 Indole derivatives as somatostatin agonists or antagonists |
| 10/05/2006 | US20060223823 Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof |
| 10/05/2006 | US20060223822 Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof |
| 10/05/2006 | US20060223819 Quinoline Derivatives as NK-3 Antagonists |
| 10/05/2006 | US20060223818 N-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-4-piperazin-1-ylmethyl-benzamide methanesulfonate; antiproliferative agent |
| 10/05/2006 | US20060223813 2-carboxamide piperazine's such as 4-hexyl-1-(thiophene-2-sulfonyl)-piperazine-2-carboxylic acid (1-ethyl-2-pyridinyl-3-yl-1H-benzoimidazol-5-yl)-amide), are potent follicle stimulating hormone receptor agonists, useful for treatment of infertility in mammals |
| 10/05/2006 | US20060223802 Derivatives of N-[phenyl(pyrrolidine-2-yl)methyl]benzamide and N-[(azepan-2-yl)phenylmethyl]benzamide, preparation method thereof and application of same in therapeutics |
| 10/05/2006 | US20060223801 Pyrrol derivatives with antibacterial activity |
| 10/05/2006 | US20060223793 Use of dopamine d3 receptor ligands for the production of drugs for treating renal function disorders |
| 10/05/2006 | US20060223792 Phenyl and pyridyl LTA4H modulators |
| 10/05/2006 | US20060223784 Method and compositions for temporarily incapacitating subjects |
| 10/05/2006 | US20060223746 Injecting an alpha v beta 3 and/or alpha v beta 5 inhibitor, sufficient to inhibit or reduce angiogenesis or neovascularization in the treated eye, into the sclera layer of the eye; (2S)-2-benzyloxycarboxamido-3-(2-guanidinomethyl-1,4-benzodioxan-6-yl)propionic acid |
| 10/05/2006 | DE102005015253A1 New pyrazole derivatives are tyrosine kinase inhibitors useful to treat e.g. solid tumors, diabetic retinopathy, age-related macular degeneration or inflammatory disease, osteoarthritis and rickets |
| 10/05/2006 | DE102005015040A1 Substituierte Tetrahydroisochinoline als MMP-Inhibitoren, Verfahren zu ihrer Herstellung und ihre Verwendung als Medikament Substituted tetrahydroisoquinolines as MMP inhibitors, to processes for their preparation and their use as a medicament |
| 10/05/2006 | DE102005014906A1 New pyrimidine compounds e.g. N-((4-ethyl-6((2-(trifluoromethyl) pyridine-4-yl)oxy) pyrimidine-2-yl)methyl) cyclopropane carboxamide useful for combating weeds |
| 10/05/2006 | DE102005014638A1 Substituierte Pyrazolyloxyphenylderivate als Herbizide Substituted Pyrazolyloxyphenylderivate as herbicides |
| 10/05/2006 | DE102005000666B3 Sulfonylpyrrolidine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel Sulfonylpyrrolidine, processes for their preparation and their use as medicaments |
| 10/05/2006 | CA2603360A1 Piperazinyl substituted cyclohexane 1,4-diamines |
| 10/05/2006 | CA2603126A1 Spirocyclic heterocyclic derivatives and methods of their use |
| 10/05/2006 | CA2603125A1 Thienopyridine derivative, quinoline derivatives,and quinazoline derivatives, having c-met autophosphorylation inhibiting activity |